These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. High-dose chemotherapy and autologous stem cell transplantation in advanced epithelial ovarian cancer. Cure H; Legros M; Fleury J; Dauplat J; Condat P; Choufi B; Chollet P; Plagne R Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S34-5. PubMed ID: 8899168 [No Abstract] [Full Text] [Related]
3. [Study by the Working Group in Gynecologic Oncology for therapeutic optimization in advanced FIGO IIb-IV ovarian carcinoma: cisplatin-paclitaxel vs. carboplatin-paclitaxel. AGO Protocol Ovar-3]. Mettler L Zentralbl Gynakol; 1996; 118(6):379-4. PubMed ID: 8768017 [No Abstract] [Full Text] [Related]
4. [Ovarian cancer treatment from the standpoint of the gynecologic oncologist]. Sugiyama T; Yoshizaki A; Hatayama S Gan To Kagaku Ryoho; 2007 Jul; 34(7):1011-6. PubMed ID: 17637537 [TBL] [Abstract][Full Text] [Related]
5. Medical therapy of advanced malignant epithelial tumours of the ovary. Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983 [TBL] [Abstract][Full Text] [Related]
6. Medical treatment of epithelial ovarian cancer. González-Martín AJ Expert Rev Anticancer Ther; 2004 Dec; 4(6):1125-43. PubMed ID: 15606338 [TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel. Ozols RF; Bookman MA; du Bois A; Pfisterer J; Reuss A; Young RC Gynecol Oncol; 2006 Oct; 103(1):1-6. PubMed ID: 16904166 [No Abstract] [Full Text] [Related]
8. The management of ovarian cancer. Ford M; Murdoch J Br J Hosp Med; 1997 Dec; 58(11):581-3. PubMed ID: 10193477 [No Abstract] [Full Text] [Related]
9. [What is current status? Current status in the primary therapy of advanced ovarian cancer]. du Bois A Krankenpfl J; 1999; 37(1-2):32-4. PubMed ID: 10401374 [No Abstract] [Full Text] [Related]
10. "MECCA": a developmental, dose-intensive, non-cross-resistant platinum-based chemotherapy for advanced ovarian cancer. Hoskins PJ; Swenerton KD; Pike JA; McMurtrie EM; Lee N Gynecol Oncol; 1996 Dec; 63(3):345-51. PubMed ID: 8946870 [TBL] [Abstract][Full Text] [Related]
11. LTE-commenting on "Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer" (90: 163-9). Eisenkop SM Gynecol Oncol; 2004 Mar; 92(3):1017-8; author reply 1018-9. PubMed ID: 14984983 [No Abstract] [Full Text] [Related]
12. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S; J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344 [TBL] [Abstract][Full Text] [Related]
13. [Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma]. Zhao XD; Zhang Q; Zhang Y Ai Zheng; 2005 Aug; 24(8):1002-5. PubMed ID: 16086882 [TBL] [Abstract][Full Text] [Related]
14. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer. Carey MS; Bacon M; Tu D; Butler L; Bezjak A; Stuart GC Gynecol Oncol; 2008 Jan; 108(1):100-5. PubMed ID: 17920108 [TBL] [Abstract][Full Text] [Related]
15. [Paclitaxel/carboplatin in first line treatment of advanced ovarian carcinoma]. Meerpohl HG Praxis (Bern 1994); 1999 Mar; 88(12):513-8. PubMed ID: 10235026 [TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors of ovarian cancer]. Ochiai K Gan To Kagaku Ryoho; 2006 Dec; 33(13):2014-9. PubMed ID: 17197745 [TBL] [Abstract][Full Text] [Related]
17. [Is there a standard therapy in advanced ovarian carcinoma?]. Köchli OR Praxis (Bern 1994); 1999 Jan; 88(4):123-5. PubMed ID: 10067114 [No Abstract] [Full Text] [Related]
18. [Prognostic factors and better survival rate after the treatment of advanced ovarian cancer with neoadjuvant chemotherapy]. Ivanov S; Ivanov S; Khadzhiolov N Akush Ginekol (Sofiia); 2004; 43(6):17-9. PubMed ID: 15669647 [TBL] [Abstract][Full Text] [Related]